Aytu Biopharma, Inc
AYTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385818
No open-market purchases or sales by Aytu Biopharma, Inc insiders were filed in the last 90 days; 38 institutions reported holding it in 13F filings for Q2 2026, worth $8.25M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Aytu Biopharma, Inc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- −3 vs. Q3 2021
- Shares held
- 3.82M
- −424.1K (−10.0%) vs. Q3 2021
- Total value
- $5.10M
- −$7.13M (−58.3%) vs. Q3 2021
- New holders
- 6
- 9 more added
- Sold out
- 9
- 15 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AYTU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 38 | $8.25M |
| Q1 2026 | 37 | $10.7M |
| Q4 2025 | 39 | $9.81M |
| Q3 2025 | 33 | $6.73M |
| Q2 2025 | 32 | $7.45M |
| Q1 2025 | 31 | $2.49M |
| Q4 2024 | 29 | $3.19M |
| Q3 2024 | 24 | $4.81M |
| Q2 2024 | 27 | $5.99M |
| Q1 2024 | 27 | $5.46M |
| Q4 2023 | 22 | $5.02M |
| Q3 2023 | 22 | $4.65M |
| Q2 2023 | 21 | $2.73M |
| Q1 2023 | 21 | $1.21M |
| Q4 2022 | 42 | $1.52M |
| Q3 2022 | 53 | $1.64M |
| Q2 2022 | 41 | $2.50M |
| Q1 2022 | 44 | $6.02M |
| Q4 2021 | 46 | $5.10M |
| Q3 2021 | 49 | $12.2M |
| Q2 2021 | 61 | $26.0M |
| Q1 2021 | 72 | $48.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Aytu Biopharma, Inc; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Focused Wealth Management, Inc | 209 | $0 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 8 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Optimum Investment Advisors | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1 | $0 | 0.00% | 00.0% | Unchanged |
| JFS Wealth Advisors, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| JJJ Advisors Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Aspire Private Capital, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 21 | $0 | 0.00% | 00.0% | Unchanged |
| CVA Family Office, LLC | 1 | $0 | 0.00% | +1 | New |
| Royal Bank of Canada | 508 | $1.00K | 0.00% | −76−13.0% | Reduced |
| Bank of America Corp | 1,196 | $2.00K | 0.00% | −5,521−82.2% | Reduced |
| Clearstead Advisors, LLC | 1,421 | $2.00K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 1,200 | $2.00K | 0.00% | +600+100.0% | Added |
| Wells Fargo & Company | 2,776 | $4.00K | 0.00% | −337−10.8% | Reduced |
| Federated Hermes, Inc. | 3,206 | $4.00K | 0.00% | +2,542+382.8% | Added |
| Group One Trading, L.P. | 3,390 | $5.00K | 0.00% | −18,604−84.6% | Reduced |
| Advisor Group Holdings, Inc. | 6,607 | $9.00K | 0.00% | −2,003−23.3% | Reduced |
| Bank of New York Mellon Corp | 10,414 | $14.0K | 0.00% | 00.0% | Unchanged |
| Sigma Planning Corp | 10,116 | $14.0K | 0.00% | +96+1.0% | Added |
| Squarepoint Ops LLC | 10,087 | $14.0K | 0.00% | +10,087 | New |
| Hunter Associates Investment Management LLC | 10,880 | $15.0K | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 12,444 | $17.0K | 0.00% | +12,444 | New |
| UBS Group AG | 14,632 | $20.0K | 0.00% | +13,050+824.9% | Added |
| Schonfeld Strategic Advisors LLC | 17,000 | $23.0K | 0.00% | −3,200−15.8% | Reduced |
| Two Sigma Advisers, LP | 17,430 | $24.0K | 0.00% | +17,430 | New |
| Tower Research Capital LLC (TRC) | 29,116 | $39.0K | 0.00% | +27,574+1,788.2% | Added |
| Susquehanna International Group, LLP | 32,028 | $43.0K | 0.00% | −124,343−79.5% | Reduced |
| Goldman Sachs Group Inc | 40,867 | $55.0K | 0.00% | −7,726−15.9% | Reduced |
| Northern Trust Corp | 48,843 | $66.0K | 0.00% | −247−0.5% | Reduced |
| Marshall Wace, LLP | 52,001 | $70.0K | 0.00% | +52,001 | New |
| Occudo Quantitative Strategies LP | 61,246 | $83.0K | 0.01% | −12,013−16.4% | Reduced |
| Susquehanna Fundamental Investments, LLC | 71,625 | $97.0K | 0.00% | −9,239−11.4% | Reduced |
| State Street Corp | 97,684 | $132.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 98,127 | $132.0K | 0.00% | +10,558+12.1% | Added |
| Commonwealth Equity Services, LLC | 107,786 | $145.0K | 0.00% | +68+0.1% | Added |
| D. E. Shaw & Co., Inc. | 109,638 | $148.0K | 0.00% | −83,721−43.3% | Reduced |
| Morgan Stanley | 190,142 | $257.0K | 0.00% | −187,780−49.7% | Reduced |
| Geode Capital Management, LLC | 257,433 | $347.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 295,779 | $399.0K | 0.00% | −64,477−17.9% | Reduced |
| BlackRock Inc. | 548,724 | $741.0K | 0.00% | +49,772+10.0% | Added |
| Renaissance Technologies LLC | 665,069 | $898.0K | 0.00% | +4,465+0.7% | Added |
| Vanguard Group Inc | 943,645 | $1.27M | 0.00% | −39,742−4.0% | Reduced |
| Piper Sandler & Co. | 49,590 | – | – | +49,590 | New |
| Winton Group Ltd | 0 | $0 | 0.00% | −57,452−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −27,286−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −15,990−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −723−100.0% | Sold out |
| Stonebridge Capital Advisors LLC | 0 | $0 | 0.00% | −761−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Capital Advisory Group Advisory Services, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |